Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

CD 19 CAR T-Cell Therapy in R/R B Cell Malignancies : A Real World Experience from CAR T Working Group, Delhi Ncr ,India

Prashant Mehta, Pravas Mishra, Dinesh Bhurani, Vidit Kapoor, Esha Kaul, Rayaz Ahmed, Saphalta Baghmar, Swati Pabbi, Rahul Katharia, Nupur Das, Narendra Agrawal, Rohan Halder, Roy Palatty, Reema Singh, Faran Naim, Jagsahib Kaur

Blood (2024) 144 (Supplement 1): 7772.

https://doi.org/10.1182/blood-2024-205903

Published: 2024

Journal Articles

Prephase Rituximab Followed By Cladirabine in Newly Diagnosed Hairy Cell Leukaemia: A Tertiary Care Center Experience from North India

Tribikram Panda, Reema Singh, Rohan Halder, Roy Palatty, Nakul Tikare, Sakshi Bhatnagar, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani

Blood (2024) 144 (Supplement 1): 6335.

https://doi.org/10.1182/blood-2024-204545

Published: 2024

Journal Articles

Response Adapted Dasatinib De-Escalation Strategy Compared to Upfront Low-Dose Dasatinib: A Prospective Cohort Study

Reema Singh, Sujay Rainchwar, Sakshi Bhatnagar, Nakul Tikare, Roy Palatty, Tribikram Panda, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani, Rohan Halder

Blood (2024) 144 (Supplement 1): 3154.

https://doi.org/10.1182/blood-2024-206740

Published: 2024

Journal Articles

Gilteritinib for FLT3 Mutated r/r AML: Is the Reality Admirable?

Disha Disha, Aakanksha Singh, Rohan Halder, Roy Palatty, Narendra Agrawal, Tribikram Panda, Nakul Tikare, Rayaz Ahmed, Dinesh Bhurani

Blood (2024) 144 (Supplement 1): 5979.

https://doi.org/10.1182/blood-2024-208207

Published: 2024

Journal Articles

Casting Hope, Defying Odds: Unveiling the Impact of Haplo-Identical Stem Cell Transplant in Myeloid Malignancies - a Tertiary Cancer Care Center Experience

Reema Singh, Sujay Rainchwar, Rohan Halder, Niharika Bhatia, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal

Blood (2023) 142 (Supplement 1): 6983.

https://doi.org/10.1182/blood-2023-181474

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplant for High-Risk Transfusion Dependent Thalassemia [Tdt] - a Comparative Analysis of Flu/Bu/Cy/ATG Versus Flu/Thio/Treo Regimen

Rohan Halder, Reshmi Harikumar Pillai, Vinayak Hemant Gupta, Sujay Rainchwar, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Narendra Agrawal, Reema Singh, Dinesh Bhurani

Blood (2023) 142 (Supplement 1): 4961.

https://doi.org/10.1182/blood-2023-186817

Published: 2023

Journal Articles

Risk and Response Adapted Approach for Treatment of Myeloma: Pushing Autologous Transplant Down the Hierarchy

Aakanksha Singh, Reema Singh, Rohan Halder, Karuna Jha, Tribikram Panda, Amir Khan Maroof, Niharika Bhatia, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal

Blood (2023) 142 (Supplement 1): 3600.

https://doi.org/10.1182/blood-2023-186745

Published: 2023

Journal Articles

A Retrospective Comparative Analysis of Intensive Vs. Non-Intensive Chemotherapy in Treatment Naïve Acute Myeloid Leukemia (AML) Patients in India

Mohd Rizwan Mohamad Anwar Shaikh, Bhumika Singh, Reema Singh, Rohan Halder, Karuna Jha, Tribikram Panda, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani

Blood (2023) 142 (Supplement 1): 5842.

https://doi.org/10.1182/blood-2023-188838

Published: 2023

Journal Articles

Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

Reema Singh, Rohan Halder, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani

Blood (2022) 140 (Supplement 1): 11713–11715.

https://doi.org/10.1182/blood-2022-162124

Published: 2022

Journal Articles

Retrospective Study of Treatment Free Remission in Patients with Chronic Myeloid Leukaemia(CML) Treated at Tertiary Care Oncology Centre from India

Megha Verma, Rohan Halder, Reema Singh, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani

Blood (2022) 140 (Supplement 1): 12222.

https://doi.org/10.1182/blood-2022-168574

Published: 2022

Journal Articles

An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase

Reema Singh, Rohan Halder, Jyotsna Kapoor, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani

Blood (2022) 140 (Supplement 1): 12197–12199.

https://doi.org/10.1182/blood-2022-158453

Published: 2022

Journal Articles

Individualized AML Induction with Venetoclax Based Therapy in Unfit Treatment Naïve Patients Aged ≤ 60 Years: A Real World Perspective from India

Mohd Rizwan Mohamad Anwar Shaikh, Pallavi Mehta, Sumeet Prakash Mirgh, Rohan Halder, Narendra Agrawal, Vishvdeep Khushoo, Rayaz Ahmed, Bhaarat Folbs, Divya Pratihast, Nitin Bansal, Dinesh Bhurani

Blood (2021) 138 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2021-150435

Published: 2021

NARROW

CD 19 CAR T-Cell Therapy in R/R B Cell Malignancies : A Real World Experience from CAR T Working Group, Delhi Ncr ,India

Prephase Rituximab Followed By Cladirabine in Newly Diagnosed Hairy Cell Leukaemia: A Tertiary Care Center Experience from North India

Response Adapted Dasatinib De-Escalation Strategy Compared to Upfront Low-Dose Dasatinib: A Prospective Cohort Study

Gilteritinib for FLT3 Mutated r/r AML: Is the Reality Admirable?

Casting Hope, Defying Odds: Unveiling the Impact of Haplo-Identical Stem Cell Transplant in Myeloid Malignancies - a Tertiary Cancer Care Center Experience

Allogeneic Stem Cell Transplant for High-Risk Transfusion Dependent Thalassemia [Tdt] - a Comparative Analysis of Flu/Bu/Cy/ATG Versus Flu/Thio/Treo Regimen

Risk and Response Adapted Approach for Treatment of Myeloma: Pushing Autologous Transplant Down the Hierarchy

A Retrospective Comparative Analysis of Intensive Vs. Non-Intensive Chemotherapy in Treatment Naïve Acute Myeloid Leukemia (AML) Patients in India

Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

Retrospective Study of Treatment Free Remission in Patients with Chronic Myeloid Leukaemia(CML) Treated at Tertiary Care Oncology Centre from India

An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase

Individualized AML Induction with Venetoclax Based Therapy in Unfit Treatment Naïve Patients Aged ≤ 60 Years: A Real World Perspective from India

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only